Global Healthcare Cold Chain Logistics Market Share, Size and Forecast 2017-2022

1

Global Healthcare Cold Chain Logistics Market
Report 2017-2021
Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Growth of Global Healthcare Cold Chain Logistics
Market Driven by Increasing Demand for
Temperature Sensitive Healthcare Products The
global healthcare cold chain logistics market has
grown significantly, owing to the increasing
demand for biopharmaceuticals and vaccines. Also,
increase in the number of clinical trials, which
employ temperature sensitive samples, have
stimulated the market growth. According to
IMARC Groups new report, titled Global
Healthcare Cold Chain Logistics Market Report
Forecast (2017-2022), the global healthcare cold
chain logistics market reached a value of US
0.22 Billion in 2016, growing at a CAGR of 10
during 2009-2016. The growth of market can be
attributed to strong sales growth of products
requiring cold chain logistics and stricter
government regulations regarding efficient
storage, handling and transportation of
temperature sensitive material. Owing to
increasing demand for healthcare cold chain
logistics in various segments, the market is
expected to reach a value of US 0.39 Billion by
2022, growing at a CAGR of 8 during
2017-2022. Request sample of the report
http//www.imarcgroup.com/request?typereportid7
19flagB
4
Report Description and Highlights
Report Description

• Highlights of the global healthcare cold chain
  logistics market
• Vaccines represent the largest sector requiring
  healthcare cold chain logistics.
• Cold chain transport services dominated the
  market, followed by packaging and
  instrumentation.
• North America is the largest market for cold
  chain healthcare logistics.
• The need for healthcare cold chain logistics is
  primarily felt in three major segments
  biopharmaceuticals, vaccines and clinical trials.
  Biopharmaceuticals are generally complex protein
  molecules and their efficacy requires temperature
  specific logistics. Any abrupt temperature change
  may lead to loss of chemical activity and make
  biopharmaceuticals harmful for human body.
  Moreover, increasing number of clinical trials
  employing temperature sensitive materials like
  blood sample, tissue sample and certain drugs,
  has stimulated the market growth. Also, demand
  for vaccines has increased, owing to the mass
  immunization programmes conducted by various
  government and non-government organisations. Like
  biopharmaceuticals, vaccines are also temperature
  sensitive and their potency may reduce on
  exposure to temperature variations. Driven by the
  increasing outsourcing trends in the
  pharmaceutical and biopharmaceutical industry,
  the cold chain logistics demand for drugs,
  vaccines and clinical trial materials is expected
  to increase significantly.

5
Report Description and Highlights
Report Description
6
Report Description and Highlights
Report Description

• To get more information, please visit _at_
  http//www.imarcgroup.com/home-automation-system-m
  arket
• On the basis of product, vaccines drive the
  demand for healthcare cold chain logistics
  market, followed by clinical trials and
  biopharmaceuticals. On the basis of segment,
  transportation accounts for more than half of the
  global cold chain logistic services. Other major
  segments are packaging and instrumentation. On
  the basis of region, North America is the largest
  market, followed by Asia-Pacific, Europe and
  others. Asia-Pacific is the fastest growing
  region, owing to the developing economies of
  China, India, South Korea, which are emerging as
  major destinations for outsourcing clinical
  trials, drug manufacturing and pathology testing.
  Some of the key players operating in this market
  are World Courier, DHL, FedEx, United Parcel
  Service, Kuehne and Nagel, Cavalier Logistics, DB
  Schenker, Life ConEx, American Airlines Cargo,
  Continental Air Cargo and Marken.
• The report by IMARC Group has examined the global
  healthcare cold chain logistics market on the
  basis of
• Product
• Vaccines
• Clinical trials
• Biopharmaceuticals

7
Report Description and Highlights
Report Description

• Segment
• Transportation
• Packaging
• Instrumentation
• Region
• North America
• Europe
• Asia pacific
• Rest of the world
• Key Players
• World Courier
• DHL
• FedEx
• United Parcel Service
• Kuehne and Nagel
• Cavalier Logistics

8
Report Description and Highlights
Report Description

• DB Schenker
• Life ConEx
• American Airlines Cargo
• Continental Air Cargo
• Marken.
• Browse Related Reports
•  
• US Generic Injectables Market _at_
  http//www.imarcgroup.com/us-generic-injectables-m
  arket
• Global Anti-Aging Market _at_ http//www.imarcgroup.c
  om/anti-aging-market

9
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
10

Contact Us